Parasitic Disease: Clinical Trials

4 trials for Parasitic Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 active not recruiting. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 3, Active not recruiting 1
Phase 21Completed 1

Follow Parasitic Disease: new trials by email Literature Review of Parasitic Disease trials Research Report on Parasitic Disease

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess the Safety and Effectiveness of Two Experimental Malaria Vaccines
RH5.1 and/or RH5.2-VLP with Matrix-M - Malaria, Malaria,Falciparum
Phase 1 / Phase 2CompletedUniversity of Oxford412023-08-182026-07-20
A Study to Compare Two Dosing Regimens for a New Malaria Vaccine
Matrix M with RH5.1 - Malaria, Malaria,Falciparum
Phase 1Active not recruitingUniversity of Oxford242023-06-062024-10-04
Pyronaridine in Healthy Adult Participants Infected With Blood Stage Malaria
Pyronaridine, P. falciparum IBSM infection - Malaria,Falciparum, Malaria
Phase 1CompletedMedicines for Malaria Venture102022-04-042025-04-16
Study in Blood Stage Malaria Infection After DVI of Cryopreserved P. Falciparum (NF54 Strain) Sporozoites
Artemether-Lumefantrine 20 Mg-120 Mg Oral Tablet, PfSPZ-DVI Challenge - Malaria,Falciparum, Parasitemia
Phase 1CompletedMedicines for Malaria Venture162020-02-192021-09-05

Narrower conditions

Malaria (4)  ·  Malaria, Falciparum (4)  ·  Parasitic Diseases (4)  ·  Protozoan Infections (3)  ·  Infections (2)  ·  Parasitemia (2)  ·  Vector Borne Diseases (2)

Broader conditions

Mosquito-Borne Diseases (4)  ·  Infections (2)  ·  Inflammation (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Sepsis (2)  ·  Systemic Inflammatory Response Syndrome (2)  ·  Vector Borne Diseases (2)  ·  Protozoan Infections (1)

Interventions

Matrix-M (2)  ·  Artemether, Lumefantrine Drug Combination (1)  ·  pyronaridine (1)

Sponsors

Medicines for Malaria Venture (2)  ·  University of Oxford (2)

Countries

United Kingdom (2)  ·  Australia (1)  ·  Belgium (1)

Top investigators

Angela Minassian, Dr (1)  ·  Farouk Chughlay, MD (1)

NIH funding

2019 (1)